Sign in
4

Changes in Ownership

Zentalis Pharmaceuticals, Inc. Filed Acc 0000899243-20-010601

Chief Operating Officer acquired 99,246 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bunker Kevin D. · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-07 Grant or award : show line 1 in the form +99,246 544,650 D
Loading xslF345X03/doc4.xml…